• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭伴中间范围和射血分数保留患者的心外膜脂肪。

Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.

机构信息

Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Eur J Heart Fail. 2018 Nov;20(11):1559-1566. doi: 10.1002/ejhf.1283. Epub 2018 Aug 1.

DOI:10.1002/ejhf.1283
PMID:30070041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6607508/
Abstract

AIMS

Adipose tissue and inflammation may play a role in the pathophysiology of patients with heart failure (HF) with mildly reduced or preserved ejection fraction. We therefore investigated epicardial fat in patients with HF with preserved (HFpEF) and mid-range ejection fraction (HFmrEF), and related this to co-morbidities, plasma biomarkers and cardiac structure.

METHODS AND RESULTS

A total of 64 HF patients with left ventricular ejection fraction >40% and 20 controls underwent routine cardiac magnetic resonance examination. Epicardial fat volume was quantified on short-axis cine stacks covering the entire epicardium and was related to clinical correlates, biomarkers associated with inflammation and myocardial injury, and cardiac function and contractility on cardiac magnetic resonance. HF patients and controls were of comparable age, sex and body mass index. Total epicardial fat volume was significantly higher in HF patients compared to controls (107 mL/m vs. 77 mL/m , P <0.0001). HF patients with atrial fibrillation and/or type 2 diabetes mellitus had more epicardial fat than HF patients without these co-morbidities (116 vs. 100 mL/m , P =0.03, and 120 vs. 97 mL/m , P =0.001, respectively). Creatine kinase-MB, troponin T and glycated haemoglobin in patients with HF were positively correlated with epicardial fat volume (R =0.37, P =0.006; R =0.35, P =0.01; and R =0.42, P =0.002, respectively).

CONCLUSION

Heart failure patients had more epicardial fat compared to controls, despite similar body mass index. Epicardial fat volume was associated with the presence of atrial fibrillation and type 2 diabetes mellitus and with biomarkers related to myocardial injury. The clinical implications of these findings are unclear, but warrant further investigation.

摘要

目的

脂肪组织和炎症可能在射血分数轻度降低或保留的心力衰竭(HF)患者的病理生理学中起作用。因此,我们研究了射血分数保留的心力衰竭(HFpEF)和中等范围射血分数的心力衰竭(HFmrEF)患者的心外膜脂肪,并将其与合并症、血浆生物标志物和心脏结构相关联。

方法和结果

共有 64 名左心室射血分数>40%的 HF 患者和 20 名对照者接受了常规心脏磁共振检查。在心外膜的短轴电影堆栈上对心外膜脂肪体积进行量化,并将其与临床相关因素、与炎症和心肌损伤相关的生物标志物以及心脏磁共振上的心脏功能和收缩性相关联。HF 患者和对照者的年龄、性别和体重指数相当。HF 患者的总心外膜脂肪量明显高于对照者(107 mL/m 与 77 mL/m ,P <0.0001)。有心房颤动和/或 2 型糖尿病的 HF 患者比没有这些合并症的 HF 患者有更多的心外膜脂肪(116 与 100 mL/m ,P =0.03 和 120 与 97 mL/m ,P =0.001)。HF 患者的肌酸激酶-MB、肌钙蛋白 T 和糖化血红蛋白与心外膜脂肪量呈正相关(R =0.37,P =0.006;R =0.35,P =0.01 和 R =0.42,P =0.002)。

结论

尽管体重指数相似,但与对照者相比,HF 患者的心外膜脂肪更多。心外膜脂肪量与心房颤动和 2 型糖尿病的存在以及与心肌损伤相关的生物标志物相关。这些发现的临床意义尚不清楚,但需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41d3/6607508/b7321e090bb5/EJHF-20-1559-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41d3/6607508/9b0394c463c9/EJHF-20-1559-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41d3/6607508/68391d194728/EJHF-20-1559-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41d3/6607508/b7321e090bb5/EJHF-20-1559-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41d3/6607508/9b0394c463c9/EJHF-20-1559-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41d3/6607508/68391d194728/EJHF-20-1559-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41d3/6607508/b7321e090bb5/EJHF-20-1559-g003.jpg

相似文献

1
Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.心力衰竭伴中间范围和射血分数保留患者的心外膜脂肪。
Eur J Heart Fail. 2018 Nov;20(11):1559-1566. doi: 10.1002/ejhf.1283. Epub 2018 Aug 1.
2
The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.高敏心肌肌钙蛋白检测对射血分数保留与降低的稳定心力衰竭患者不良事件的预后价值。
Eur J Heart Fail. 2017 Dec;19(12):1638-1647. doi: 10.1002/ejhf.911. Epub 2017 Aug 28.
3
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.左心房射血分数与射血分数保留心力衰竭的结局。
Int J Cardiovasc Imaging. 2020 Jan;36(1):101-110. doi: 10.1007/s10554-019-01684-9. Epub 2019 Aug 10.
4
Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients.心力衰竭患者心外膜脂肪的演变及其与心肌弥漫性纤维化的相关性。
J Clin Lipidol. 2017 Nov-Dec;11(6):1421-1431. doi: 10.1016/j.jacl.2017.08.018. Epub 2017 Sep 4.
5
Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.N 端脑利钠肽前体在射血分数保留型、中间范围型和降低型心力衰竭中的相关性及其预后和鉴别诊断作用。
J Card Fail. 2018 Jun;24(6):365-374. doi: 10.1016/j.cardfail.2018.03.010. Epub 2018 Mar 27.
6
Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.入院时可溶性ST2和N末端脑钠肽前体在射血分数保留、中等范围和降低的心力衰竭中的预后价值。
Acta Cardiol. 2018 Feb;73(1):41-48. doi: 10.1080/00015385.2017.1325617. Epub 2017 Sep 25.
7
Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.中射血分数慢性心力衰竭的生物特征分析与生物预后评估。
Int J Cardiol. 2018 Apr 15;257:188-192. doi: 10.1016/j.ijcard.2018.01.119. Epub 2018 Jan 31.
8
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.生长分化因子 15、ST2、高敏肌钙蛋白 T 和 N 末端脑利钠肽前体在射血分数保留型与降低型心力衰竭中的比较。
Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5.
9
Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction.心外膜脂肪组织与射血分数中间值和保留型心力衰竭患者的结局。
Circ Heart Fail. 2022 Mar;15(3):e009238. doi: 10.1161/CIRCHEARTFAILURE.121.009238. Epub 2021 Dec 22.
10
Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.左心房容积和左心室质量指数在射血分数保留和降低的心力衰竭中的变化。
ESC Heart Fail. 2021 Aug;8(4):2458-2466. doi: 10.1002/ehf2.13366. Epub 2021 Jun 4.

引用本文的文献

1
Epicardial Adipose Tissue-A Novel Therapeutic Target in Obesity Cardiomyopathy.心外膜脂肪组织——肥胖性心肌病的新型治疗靶点。
Int J Mol Sci. 2025 Aug 18;26(16):7963. doi: 10.3390/ijms26167963.
2
Underpinnings of heart failure with preserved ejection fraction in women - From prevention to improving function. A co-publication with the American Journal of Preventive Cardiology and the Journal of Cardiac Failure.女性射血分数保留的心力衰竭的基础——从预防到改善功能。与《美国预防心脏病学杂志》和《心力衰竭杂志》合作出版。
Am J Prev Cardiol. 2025 Feb 19;23:100928. doi: 10.1016/j.ajpc.2025.100928. eCollection 2025 Sep.
3

本文引用的文献

1
Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium.心外膜脂肪组织可能介导肥胖和炎症对心肌的有害影响。
J Am Coll Cardiol. 2018 May 22;71(20):2360-2372. doi: 10.1016/j.jacc.2018.03.509.
2
Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2.肥胖相关性射血分数保留型心力衰竭:联合应用醛固酮、脑啡肽酶和钠-葡萄糖共转运蛋白-2 抑制剂的机制原理。
JACC Heart Fail. 2018 Aug;6(8):633-639. doi: 10.1016/j.jchf.2018.01.009. Epub 2018 Mar 7.
3
Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients.
Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease.
心力衰竭与代谢功能障碍相关脂肪性肝病联合管理的指南导向性医学策略。
Commun Med (Lond). 2025 Jul 28;5(1):312. doi: 10.1038/s43856-025-00951-2.
4
Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic Control.2型糖尿病患者心外膜脂肪组织与新型炎症及心力衰竭生物标志物的关联:代谢控制的影响
J Clin Med. 2025 Jul 2;14(13):4687. doi: 10.3390/jcm14134687.
5
Prognostic value of epicardial adipose tissue in heart failure: a systematic review and meta-analysis.心外膜脂肪组织在心力衰竭中的预后价值:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2025 Jun 26;12:1618614. doi: 10.3389/fcvm.2025.1618614. eCollection 2025.
6
Reductions in Epicardial Adipose Tissue and Mediastinal Fat Are Associated with Improved Cardiac Function.心外膜脂肪组织和纵隔脂肪减少与心脏功能改善相关。
Obes Surg. 2025 Jul 5. doi: 10.1007/s11695-025-08000-6.
7
Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment.射血分数保留的心脏代谢性心力衰竭:从分子特征到个性化治疗
Cardiovasc Diabetol. 2025 Jul 3;24(1):265. doi: 10.1186/s12933-025-02774-w.
8
The Role of Epicardial Fat Thickness and B-type Natriuretic Peptide (BNP)/N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) in Heart Failure Risk Stratification: A Systematic Review.心外膜脂肪厚度与B型利钠肽(BNP)/N末端B型利钠肽原(NT-proBNP)在心力衰竭风险分层中的作用:一项系统评价
Cureus. 2025 May 15;17(5):e84184. doi: 10.7759/cureus.84184. eCollection 2025 May.
9
CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease.心脏-肾脏-糖尿病-肝脏-代谢综合征(CARDIAL-MS):一种综合多系统代谢疾病的新定义。
Diabetol Metab Syndr. 2025 Jun 16;17(1):218. doi: 10.1186/s13098-025-01796-4.
10
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC.心力衰竭与肥胖:转化方法与治疗前景。欧洲心脏病学会心力衰竭协会的科学声明。
Eur J Heart Fail. 2025 Jul;27(7):1273-1293. doi: 10.1002/ejhf.3676. Epub 2025 May 6.
心力衰竭患者心外膜脂肪的演变及其与心肌弥漫性纤维化的相关性。
J Clin Lipidol. 2017 Nov-Dec;11(6):1421-1431. doi: 10.1016/j.jacl.2017.08.018. Epub 2017 Sep 4.
4
Expression of epicardial adipose tissue thermogenic genes in patients with reduced and preserved ejection fraction heart failure.射血分数降低和保留的心力衰竭患者中心外膜脂肪组织产热基因的表达
Int J Med Sci. 2017 Jul 20;14(9):891-895. doi: 10.7150/ijms.19854. eCollection 2017.
5
Epicardial adipose tissue: at the heart of the obesity complications.心外膜脂肪组织:肥胖并发症的核心。
Acta Diabetol. 2017 Sep;54(9):805-812. doi: 10.1007/s00592-017-1020-z. Epub 2017 Jun 29.
6
Strain imaging using cardiac magnetic resonance.利用心脏磁共振成像进行应变成像。
Heart Fail Rev. 2017 Jul;22(4):465-476. doi: 10.1007/s10741-017-9621-8.
7
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.支持射血分数保留的心力衰竭存在独特肥胖表型的证据。
Circulation. 2017 Jul 4;136(1):6-19. doi: 10.1161/CIRCULATIONAHA.116.026807. Epub 2017 Apr 5.
8
Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.射血分数保留的心力衰竭与心房颤动:罪恶双生子。
J Am Coll Cardiol. 2016 Nov 15;68(20):2217-2228. doi: 10.1016/j.jacc.2016.08.048.
9
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.射血分数保留的心力衰竭的表型特异性治疗:多器官路线图
Circulation. 2016 Jul 5;134(1):73-90. doi: 10.1161/CIRCULATIONAHA.116.021884.
10
An observational study of the association among interatrial adiposity by computed tomography measure, insulin resistance, and left atrial electromechanical disturbances in heart failure.一项关于通过计算机断层扫描测量的心房间脂肪堆积、胰岛素抵抗与心力衰竭中左心房机电紊乱之间关联的观察性研究。
Medicine (Baltimore). 2016 Jun;95(24):e3912. doi: 10.1097/MD.0000000000003912.